Subcutaneous sarcoidosis.

Subcutaneous sarcoidosis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Subcutaneous sarcoidosis. Abstract Text:

Subcutaneous sarcoidosis has been reported to occur in 1.4% to 6% of patients with systemic sarcoidosis. Most reported cases are in women, most often in their fifth and sixth decades, and appear as multiple, asymptomatic, hardly indurated subcutaneous nodules without changes in the overlying epidermis. The lesions are characteristically located in the upper extremities, mainly in the forearms, and usually are bilateral and asymmetric. In most cases the lesions appear at the beginning of systemic sarcoidosis and are not associated with chronic fibrotic disease. Histopathologically, sarcoidosis is characterized by noncaseating naked granulomas involving fat lobules, with minimal to no septal involvement.

Subcutaneous sarcoidosis. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Subcutaneous sarcoidosis. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Dermatologic clinics

VOLUME: 26

Page Numbers: 553-6

Journal Abbreviation:

ISSN: 0733-8635

DAY: 16

MONTH: Oct

YEAR: 2008

Subcutaneous sarcoidosis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8300886

Subcutaneous sarcoidosis. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Subcutaneous sarcoidosis. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Subcutaneous sarcoidosis.

AFFILIATION: Department of Dermatology, Hospital de Bellvitge, IDIBELL, University of Barcelona, C/Feixa Llarga s/n, Hospitalet de Llobregat, 08907-Barcelona, Spain.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Dermatol Clin

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Subcutaneous sarcoidosis Related Publications

• Adhesion molecule expression and endothelial cell activation in cutaneous leukocytoclastic vasculitis. An immunohistologic and clinical study in 42 patients.
• Antineutrophil cytoplasmic antibodies in leukocytoclastic vasculitis.
• Colchicine in the treatment of cutaneous leukocytoclastic vasculitis. Results of a prospective, randomized controlled trial.
• Foreign bodies in granulomatous cutaneous lesions of patients with systemic sarcoidosis.
• Palmoplantar keratoderma secondary to chronic acral erythema due to tegafur.
• Subcutaneous sarcoidosis.
• Traumatic panniculitis.